Literature DB >> 19073871

Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland.

Tuula Siljander1, Outi Lyytikäinen, Susanna Vähäkuopus, Petrus Säilä, Jari Jalava, Jaana Vuopio-Varkila.   

Abstract

From 2005 to 2007, in Finland, the incidence of invasive Streptococcus pyogenes disease increased sharply, partly due to the uncommon emm84 gene becoming more prevalent from 2006 onwards. The overall case fatality rate of infections caused by strains carrying emm84 was not significantly different than that of infections caused by other types (7% versus 10%, respectively; P = 0.50).

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19073871      PMCID： PMC2643675          DOI： 10.1128/JCM.01663-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  31 in total

1.  Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates.

Authors:  Franz-Josef Schmitz; Andreas Beyer; Emmanuelle Charpentier; Birgitta Henriques Normark; Marc Schade; Ad C Fluit; Dieter Hafner; Rodger Novak
Journal:  J Infect Dis       Date:  2003-11-05       Impact factor: 5.226

2.  Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

Authors:  Katherine L O'Brien; Bernard Beall; Nancy L Barrett; Paul R Cieslak; Arthur Reingold; Monica M Farley; Richard Danila; Elizabeth R Zell; Richard Facklam; Benjamin Schwartz; Anne Schuchat
Journal:  Clin Infect Dis       Date:  2002-07-10       Impact factor: 9.079

3.  Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.

Authors:  J M Musser; A R Hauser; M H Kim; P M Schlievert; K Nelson; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

4.  Predominance of two M-types among erythromycin-resistant group A Streptococci from Greek children.

Authors:  L Zachariadou; J Papaparaskevas; I Paraskakis; A Efstratiou; A Pangalis; N J Legakis; P T Tassios
Journal:  Clin Microbiol Infect       Date:  2003-04       Impact factor: 8.067

Review 5.  Group A streptococci in the 1990s.

Authors:  A Efstratiou
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

6.  Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics.

Authors:  N P Hoe; P Kordari; R Cole; M Liu; T Palzkill; W Huang; D McLellan; G J Adams; M Hu; J Vuopio-Varkila; T R Cate; M E Pichichero; K M Edwards; J Eskola; D E Low; J M Musser
Journal:  J Infect Dis       Date:  2000-10-03       Impact factor: 5.226

7.  Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial.

Authors:  Karen L Kotloff; Mary Corretti; Kathleen Palmer; James D Campbell; Mark A Reddish; Mary C Hu; Steven S Wasserman; James B Dale
Journal:  JAMA       Date:  2004-08-11       Impact factor: 56.272

8.  Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings.

Authors:  Tuula Siljander; Matti Karppelin; Susanna Vähäkuopus; Jaana Syrjänen; Maija Toropainen; Juha Kere; Risto Vuento; Tapio Jussila; Jaana Vuopio-Varkila
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

9.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

10.  Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004.

Authors:  Theresa L Lamagni; Shona Neal; Catherine Keshishian; Neelam Alhaddad; Robert George; Georgia Duckworth; Jaana Vuopio-Varkila; Androulla Efstratiou
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883
View more
  7 in total

1.  Distribution of emm types in invasive and non-invasive group A and G streptococci.

Authors:  S Vähäkuopus; R Vuento; T Siljander; J Syrjänen; J Vuopio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-16       Impact factor: 3.267

2.  Streptococcus pyogenes bacteraemia, emm types and superantigen profiles.

Authors:  S Rantala; S Vähäkuopus; T Siljander; J Vuopio; H Huhtala; R Vuento; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-30       Impact factor: 3.267

3.  Epidemiology and emm types of invasive group A streptococcal infections in Finland, 2008-2013.

Authors:  P W Smit; L Lindholm; O Lyytikäinen; J Jalava; A Pätäri-Sampo; J Vuopio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-21       Impact factor: 3.267

4.  Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland.

Authors:  T Siljander; O Lyytikäinen; S Vähäkuopus; M Snellman; J Jalava; J Vuopio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-20       Impact factor: 3.267

5.  Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles.

Authors:  Roger Meisal; Ida K G Andreasson; E Arne Høiby; Ingeborg S Aaberge; Terje E Michaelsen; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

6.  Genomic Characteristics Behind the Spread of Bacteremic Group A Streptococcus Type emm89 in Finland, 2004-2014.

Authors:  Francesca Latronico; Waleed Nasser; Kai Puhakainen; Jukka Ollgren; Hanne-Leena Hyyryläinen; Stephen B Beres; Outi Lyytikäinen; Jari Jalava; James M Musser; Jaana Vuopio
Journal:  J Infect Dis       Date:  2016-10-05       Impact factor: 5.226

Review 7.  Invasive group a streptococcal disease: epidemiology, pathogenesis and management.

Authors:  Andrew C Steer; Theresa Lamagni; Nigel Curtis; Jonathan R Carapetis
Journal:  Drugs       Date:  2012-06-18       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.